Stephanie Tuminello | Genetic Epidemiology | Innovative Research Award

Published on by Global Genetics Award

 

Innovative Research Award

Stephanie Tuminello
Icahn School of Medicine at Mount Sinai

Stephanie Tuminello
Affiliation Icahn School of Medicine at Mount Sinai
Country United States
Scopus ID 57193871243
Documents 60
Citations 1,069
h-index 15
Subject Area Genetic Epidemiology
Event Global Genetics Awards

Stephanie Tuminello is affiliated with the Icahn School of Medicine at Mount Sinai, where her scholarly work contributes to the advancement of genetic epidemiology and related biomedical research. Her publication record, citation performance, and sustained research activity demonstrate continued engagement in understanding genetic determinants of disease, epidemiological methodologies, and translational biomedical science. Bibliometric indicators from Scopus show a substantial scholarly contribution supported by peer-reviewed publications and academic citations, reflecting the influence of her research within the international scientific community.[1]

Abstract

Stephanie Tuminello’s research portfolio focuses on genetic epidemiology through the integration of population-based investigation, molecular genetics, and clinical data analysis. Her scientific work contributes to understanding disease susceptibility, inherited genetic variation, and risk prediction using evidence-based epidemiological methodologies. The body of published literature demonstrates interdisciplinary collaboration and continued scientific productivity across multiple areas of biomedical research.[1]

Keywords

Genetic Epidemiology; Population Genetics; Human Genetics; Disease Susceptibility; Precision Medicine; Genomic Medicine; Epidemiological Research; Translational Medicine.

Introduction

Genetic epidemiology combines principles from genetics, epidemiology, and biostatistics to evaluate inherited and environmental influences on disease occurrence. Researchers working within this discipline investigate genetic risk factors, gene-environment interactions, and population-level disease patterns to improve healthcare outcomes. Stephanie Tuminello’s scholarly activities align with these objectives through peer-reviewed research that contributes to the broader understanding of genetic determinants of human health.[2]

Research Profile

According to publicly available bibliometric information, Stephanie Tuminello has authored 60 indexed publications that have collectively received more than one thousand citations, resulting in an h-index of 15. These indicators suggest sustained scholarly productivity and measurable research influence within biomedical sciences and genetic epidemiology.[1]

  • Affiliation: Icahn School of Medicine at Mount Sinai
  • Primary discipline: Genetic Epidemiology
  • Scopus-indexed publications: 60
  • Scopus citations: 1,069
  • Scopus h-index: 15

Research Contributions

The available publication record indicates contributions involving genetic risk assessment, epidemiological analysis, disease association studies, clinical research methodologies, and collaborative biomedical investigations. Such work supports improved understanding of disease mechanisms and facilitates evidence generation for future precision medicine initiatives.[1][3]

  • Population-based genetic investigations.
  • Clinical and translational epidemiological research.
  • Genetic susceptibility and disease association studies.
  • Interdisciplinary collaboration across biomedical sciences.

Publications

The author’s publication portfolio consists of peer-reviewed journal articles indexed by major scholarly databases. These publications collectively address topics within genetics, epidemiology, biomedical science, and translational research, demonstrating continued scientific productivity over multiple years.[1]

  • Research articles indexed in Scopus.
  • Collaborative multidisciplinary publications.
  • Biomedical and genetic epidemiology studies.

Research Impact

Bibliometric evidence indicates measurable academic influence through citations, publication output, and scholarly visibility. Citation metrics suggest that the published work has contributed to ongoing scientific discussions and has been referenced by researchers working in related biomedical disciplines. Such indicators are commonly employed in evaluating scientific productivity and research influence.[1]

Award Suitability

Stephanie Tuminello demonstrates characteristics generally considered during evaluation for an Innovative Research Award, including sustained publication activity, measurable citation impact, interdisciplinary collaboration, and contributions to genetic epidemiology. Recognition within an academic awards program would appropriately acknowledge continued scientific engagement while reflecting objective scholarly indicators rather than subjective assessments of scientific merit alone.[1]

Conclusion

Stephanie Tuminello has established an active academic profile through contributions to genetic epidemiology, peer-reviewed publications, and collaborative biomedical research. Publicly available bibliometric indicators demonstrate sustained scholarly productivity and research visibility, supporting recognition within academic and professional award programs dedicated to scientific excellence and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Stephanie Tuminello, Author ID 57193871243.
    Scopus.https://www.scopus.com/authid/detail.uri?authorId=57193871243
  2. Disparities in COVID-19 testing and positivity in New York City
    https://www.sciencedirect.com/science/article/pii/S0749379720302634
  3. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
    https://www.nature.com/articles/ncomms14922
  4. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City
    https://journal.chestnet.org/article/S0012-3692(20)34288-4/fulltext
  5. The impact of asthma on mortality in patients with COVID-19
    https://journal.chestnet.org/article/S0012-3692(20)31645-7/fulltext

 

 Andrea Manica | Population genetics software | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Andrea Manica
Affiliation University of Cambridge
Country United Kingdom
Scopus ID 6603416293
Documents 187
Citations 17,182
h-index 67
Subject Area Population genetics software
Event Global Genetics Awards
ORCID 0000-0003-1895-450X

 Andrea Manica

University of Cambridge, United Kingdom

The Innovative Research Award recognizes sustained scholarly excellence and significant contributions to scientific advancement. Andrea Manica, a researcher at the University of Cambridge, has established an internationally recognized research profile in evolutionary biology, population genetics, human migration, ecological modelling, and computational approaches to biodiversity research. His scholarly publications, extensive citation record, and interdisciplinary collaborations demonstrate continued influence across genetics and evolutionary sciences.[1]

Abstract

Andrea Manica’s research integrates population genetics, ecology, anthropology, computational biology, and evolutionary theory to investigate biological diversity and human evolutionary history. His work combines large-scale genomic datasets, ecological modelling, and statistical methods to improve understanding of species distributions, migration processes, adaptation, and conservation. His scholarly achievements have resulted in a substantial international research profile with extensive citations and broad interdisciplinary impact.[1][2]

Keywords

Population genetics, evolutionary biology, ecological modelling, biodiversity, human migration, computational biology, conservation genetics, statistical ecology, genomics, species distribution modelling.

Introduction

Modern genetics increasingly relies upon interdisciplinary analytical approaches capable of integrating molecular, ecological, and computational evidence. Andrea Manica’s research exemplifies this trend by combining quantitative analysis with evolutionary theory to address questions concerning biodiversity, adaptation, and demographic history. His work has contributed to both methodological development and biological discovery while supporting evidence-based conservation research.[2]

Research Profile

Andrea Manica is affiliated with the University of Cambridge and maintains an internationally visible publication record indexed in Scopus. His documented scholarly metrics include 187 indexed publications, over 17,000 citations, and an h-index of 67, reflecting consistent scientific influence across multiple research disciplines.[1]

  • Population genetics and demographic inference.
  • Human evolutionary history.
  • Ecological and environmental modelling.
  • Biodiversity and conservation science.
  • Statistical and computational biology.

Research Contributions

His investigations have improved scientific understanding of how evolutionary processes, environmental factors, and migration shape genetic diversity. By integrating computational simulations with empirical observations, his studies have informed research concerning adaptation, population structure, climate influences, and conservation planning.[2][3]

  • Development of computational approaches for population genetics.
  • Analysis of human migration and demographic history.
  • Research supporting biodiversity conservation.
  • Integration of ecological and genomic datasets.
  • Interdisciplinary collaboration across genetics and ecology.

Publications

Andrea Manica has authored numerous peer-reviewed publications appearing in internationally recognized scientific journals. His research articles are frequently cited within genetics, ecology, anthropology, conservation biology, and evolutionary science, reflecting sustained scholarly relevance.[1]

  • Population genetic analyses.
  • Evolutionary modelling studies.
  • Human demographic history research.
  • Biodiversity conservation publications.

Research Impact

The documented citation metrics indicate extensive international recognition of Andrea Manica’s scholarly work. His publications continue to support research across genetics, ecology, anthropology, and environmental sciences while influencing computational methodologies and conservation strategies. The breadth of citations reflects continued relevance across diverse scientific communities.[1]

Award Suitability

Based on publicly available scholarly indicators, Andrea Manica demonstrates characteristics consistent with recognition through an Innovative Research Award. These include a sustained publication record, internationally recognized citation impact, interdisciplinary scientific contributions, methodological innovation, and continued advancement of population genetics and evolutionary biology research. Such accomplishments align with common evaluation criteria used in academic recognition programs.[1]

Conclusion

Andrea Manica’s scholarly career reflects substantial contributions to population genetics, computational biology, biodiversity research, and evolutionary science. Through interdisciplinary collaboration and quantitative innovation, his work has strengthened scientific understanding of biological diversity and evolutionary processes. His documented academic achievements support recognition within international research award programs dedicated to scientific excellence and innovation.[2]

References

    1. Elsevier. (n.d.). Scopus author details: Andrea Manica, Author ID 6603416293. Scopus.https://www.scopus.com/authid/detail.uri?authorId=6603416293
    2. ORCID. (n.d.). Andrea Manica
      ORCID Profile.      https://orcid.org/0000-0003-1895-450X
    3. Manica, A., et al. Representative research publication. Nature.
      DOI:
      https://doi.org/10.1038/nature06258
    4. Elsevier. (n.d.). Google scholar details: Andrea Manica.
      Google scholar. https://scholar.google.com/citations?user=v8V058QAAAAJ&hl=en
    5. An African origin for the intimate association between humans and Helicobacter pylori
       https://www.nature.com/articles/nature05562

Vanderlei Bagnato | Host Genetics | Best Researcher Award

Published on by Global Genetics Award

Dr. Vanderlei Bagnato | Host Genetics | Best Researcher Award

Texas A&M University | United States

Dr. Vanderlei Bagnato is a distinguished physicist and engineer whose illustrious career spans over four decades of groundbreaking research, academic leadership, and innovation in optics, photonics, and biomedical applications of laser technology. He earned dual B.S. degrees in Materials Engineering from the Federal University of São Carlos (UFSCAR) and in Physics from the University of São Paulo (USP), followed by an M.S. in Physics from USP and a Ph.D. in Physics from the Massachusetts Institute of Technology (MIT). Currently, he serves as a Professor of Biomedical Engineering at Texas A&M University while holding a full professorship at the Institute of Physics at São Carlos (IFSC/USP), Brazil. Over the years, Dr. Bagnato has held numerous prestigious roles, including Director of IFSC, Coordinator of the USP Innovation Agency, and long-term Coordinator of Brazil’s National Institute of Science and Technology of Optics and Photonics. His pioneering research and leadership have earned him global recognition and a multitude of honors, such as election to the U.S. National Academy of Engineering, the Willis E. Lamb Award for Laser Science and Quantum Optics, and the Robert E. Hopkins Leadership Award from Optica. He has also been honored with major national and international distinctions, including Brazil’s Admiral Álvaro Alberto Award, the CBMM Science & Technology Award, and the Commander of the National Order of Scientific Merit. Dr. Bagnato’s current research is supported by major grants such as the Texas Governor’s University Research Initiative and the Cancer Prevention and Research Institute of Texas, focusing on advanced biophotonics, laser therapy, and machine learning applications for healthcare and material analysis. Through his scientific leadership, prolific research output, and commitment to innovation, Dr. Vanderlei Bagnato continues to shape the future of optics and photonics in both fundamental science and translational biomedical engineering.

Profiles: Scopus | Google Scholar

Featured Publications

"Comparative analysis of ALA mediated sonodynamic therapy considering tumor size, light combination and ultrasound delivery in murine cutaneous melanoma", Scientific Reports, 2025.

"Unlocking BODIPY dye synthetic methodologies with 1H NMR monitoring and continuous flow techniques", Dyes and Pigments, 2025.

"Light-activated Zein–curcumin films for the photodynamic inactivation of bacterial biofilms: Continuous vs. intermittent illumination", Journal of Photochemistry and Photobiology B Biology, 2025.

"Vascular and tissue effects of photodynamic therapy in a murine cutaneous tumor model", Journal of Photochemistry and Photobiology B Biology, 2025.

"The Combined Photosensitizers in Antimicrobial Photodynamic Therapy: The Case of Methylene Blue and Photodithazine Against Klebsiella pneumoniae", International Journal of Molecular Sciences, 2025.

Jaina Razbek | Epidemiology | Best Scholar Award

Published on by Global Genetics Award

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

✅ Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
✅ Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
✅ Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
✅ Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data" 

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study" 

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts" 

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome" 

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models" 

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Yani Arhab | Viral Strategies | Best Researcher Award

Published on by Global Genetics Award

Dr. Yani Arhab | Viral Strategies | Best Researcher Award

SUNY Downstate Health Sciences University | United States

Author Profile

Scopus

Orcid ID

Google Scholar

YANI ARHAB, PHD 🎓🔬

EARLY ACADEMIC PURSUITS 📚

Yani Arhab’s academic journey began at the University François Rabelais of Tours (France), where he earned his BSc in Biology. During his studies, he participated in an Erasmus program, studying at Queen Mary University of London. He continued his education at University Claude Bernard Lyon1, completing his Master's in Structural & Functional Biochemistry. Yani further honed his skills during a Master’s 2 training at the ICBMS, where he worked on the structural and functional characterization of phospholipases D in plants.

PROFESSIONAL ENDEAVORS 💼

Yani's career spans multiple prestigious institutions and roles. From 2015 to 2018, he earned his PhD at the University of Lyon, where he focused on phospholipases D, under the guidance of Pr. A. Abousalham and Dr. A. Noiriel. Following this, he served as a full-time associate professor at Université Claude Bernard Lyon1 in 2018-2019. Since 2019, Yani has been a Postdoctoral Associate at the State University of New York, Downstate Medical Center, where he is studying the reconstitution of ribosomal initiation complexes on viral RNA Internal Ribosome Entry Sites (IRES) under the mentorship of Dr. Christopher Hellen and Dr. Tatyana Pestova.

CONTRIBUTIONS AND RESEARCH FOCUS ON VIRAL STRATEGIES🧬

Yani’s research focuses on biochemistry, particularly in the areas of ribosomal initiation, lipid biochemistry, and the structural and functional analysis of enzymes. His work on phospholipases D has contributed significantly to understanding lipid metabolism and its impact on cellular functions. In his current research, he is studying viral RNA IRES and their mechanisms in translation initiation, which has important implications for viral infections and potential therapeutic targets.

IMPACT AND INFLUENCE 🌍

Yani’s work is influencing multiple fields of molecular biology and biochemistry, particularly through his contributions to understanding the molecular mechanisms behind viral translation and enzyme function. His research on IRES mechanisms is helping expand our knowledge of viral RNA translation, with the potential to influence future antiviral strategies.

ACADEMIC CITATIONS 📈

Throughout his academic career, Yani Arhab has gained recognition for his innovative research, presenting his findings at international conferences such as the Translational Control Symposium at Cold Spring Harbor Laboratory and the Ribosome Structure & Function Conference. His research contributions have resulted in numerous publications and are frequently cited by peers in the fields of biochemistry, molecular biology, and virology.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Yani Arhab’s legacy is defined by his commitment to advancing our understanding of molecular biology. He has built a solid foundation of research that will continue to shape the future of biochemical research, particularly in the fields of RNA biology and viral research. Looking ahead, he plans to further investigate the complex interactions of ribosomal initiation and their implications for therapeutic development, particularly for viral diseases.

AWARDS AND SCHOLARSHIPS 🏆

  • 2015, 2016, 2018: Research funds from the Ligue National Contre le Cancer (€15,000)
  • 2017: FEBS+3 travel grant (€750)
  • 2015: Ph.D. bursary recipient

PROFESSIONAL MEMBERSHIPS 🤝

  • Member of the AFC (French Crystallography Society)
  • Member of the SFBBM (French Molecular Biology and Biochemistry Society)
  • Associate Professor in Biochemistry and Molecular Biology since 2019

TEACHING EXPERIENCE 🍎

Yani Arhab has contributed to the education of future scientists by teaching both lectures and experimental courses in biochemistry. He has mentored undergraduate students in subjects such as protein purification, lipid characterization, and enzymatic assays, fostering the next generation of researchers. Yani Arhab's work exemplifies the intersection of molecular research and practical application in medicine, showcasing his contributions to both academia and the scientific community at large.

NOTABLE PUBLICATIONS 📑

"Heterologous expression, kinetic characterization and molecular modeling of a new sn-1,3-regioselective triacylglycerol lipase from Serratia sp. W3" 

  • Authors: Eddehech, A. , Rahier, R. , Smichi, N. , Sayari, A. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2021

"Phospholipase D inhibitors screening: Probing and evaluation of ancient and novel molecules" 

  • Authors: Arhab, Y. , Bessaa, K. , Abla, H. , Abousalham, A. , Noiriel, A
  • Journal: International Journal of Biological Macromolecules
  • Year: 2021

"Corrigendum to “Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity”

  • Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2019

"Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity" 

  • Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
  • Journal: Process Biochemistry
  • Year: 2019

"Plant phospholipase D mining unravels new conserved residues important for catalytic activity" 

  • Authors: Arhab, Y. , Abousalham, A. , Noiriel, A.
  • Journal: Molecular and Cell Biology of Lipids
  • Year: 2019

Haifeng Shi | Infectious Diseases | Excellence in Research 

Published on by Global Genetics Award

Dr. Haifeng Shi | Infectious Diseases | Excellence in Research 

Jiangsu University | China

Author Profile

Scopus

Dr. Shi Haifeng: Pioneer in Metal Toxicology and Cell Damage Detection 🔬

EARLY ACADEMIC PURSUITS 🎓

Dr. Shi Haifeng's academic journey began with a Bachelor’s degree in Biochemistry from Nanjing University in 1998. His passion for biochemistry led him to pursue a Ph.D. at the Hong Kong University of Science and Technology, where he studied under the mentorship of Professor Hong Xue, earning his doctorate in 2002. This foundation set the stage for his future groundbreaking research in the field of metal ion metabolism and toxicity.

PROFESSIONAL ENDEAVORS 🧑‍🔬

After obtaining his Ph.D., Dr. Shi continued his work at the Hong Kong University of Science and Technology as a Research Associate from 2002 to 2004, further honing his research skills. He then embarked on an international academic experience as a Visiting Scholar at the National Institutes of Health (NIH), specifically within the Liver Diseases Branch of the NIDDK, from 2004 to 2009. His time at the NIH allowed him to deepen his expertise in molecular toxicology and disease mechanisms.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🧪

Dr. Shi’s research is focused on the metabolism and biological toxicity of metal ions such as iron, copper, and cadmium. His work is crucial in understanding how these metals impact biological systems, particularly in the context of heavy metal nephropathy. Additionally, his innovative work on the use of cell-free circulating cfDNA in blood as a biomarker for tissue cell damage has broad applications in medical diagnostics and environmental toxicology. His experimental models, which include yeast, silkworms, and mice, have helped to clarify the toxicological effects of metals at both molecular and systemic levels.

IMPACT AND INFLUENCE 🌍

Dr. Shi’s contributions to the scientific community are widely recognized. He has published over 70 research papers in prestigious international journals. One of his papers was recommended by Professor Alan Parrish from the University of Missouri-Columbia and listed by "Faculty Opinions" (formerly F1000Prime), a distinction reserved for papers with significant impact on their field. Another of his publications has been selected as an ESI Highly Cited Paper, placing him among the top 1% of researchers in his field.

ACADEMIC CITATIONS 📚

Dr. Shi’s work is highly cited, and his recognition as an ESI Highly Cited Researcher underscores his influence on the global scientific community. His papers continue to guide researchers in the fields of toxicology, nephropathy, and medical diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Dr. Shi Haifeng’s legacy lies in his groundbreaking work on the biological effects of heavy metals and his innovative use of cfDNA in disease detection. As a leader in his field, his future contributions are expected to expand the frontiers of biochemistry and toxicology, with significant implications for both environmental health and clinical medicine. His continued dedication to both research and education ensures that he will remain an influential figure in his field for years to come.

NOTABLE PUBLICATIONS 📑

"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy" 

  • Authors: Guo, C. , Ruan, J. , Li, Z. , Gu, J. , Shi, H.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024

"From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death" 

  • Authors: Gu, J. , Guo, C. , Ruan, J. , Gong, X. , Shi, H.
  • Journal: Apoptosis
  • Year: 2024

"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release" 

  • Authors: Xu, L. , He, L. , Li, Y. , Shi, H. , Zhu, C.
  • Journal: Biomedical Materials (Bristol)
  • Year: 2024

"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers" 

  • Authors: Xu, L. , Li, Y. , Cai, T. , Chu, Z. , Shen, X
  • Journal: Macromolecular Research
  • Year: 2024

"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation" 

  • Authors: Cao, C. , Yuan, L. , Wang, Y. , Shi, H. , Jiang, T.
  • Journal: Frontiers in Immunology
  • Year: 2024